title: Nanopharmaceutical may offer benefits in combinations.
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002166:Camptothecin / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D003505:Cyclodextrins / Q000627:therapeutic use*; D006801:Humans; D053758:Nanoparticles; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D003505:Cyclodextrins; C542292:IT-101; D002166:Camptothecin